SEC Form D · filed May 20, 2019
Finch Therapeutics Group, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
R. J. Price · Somerville, MADirectorAndrew Mulderry · Somerville, MADirectorJames Burgess · Somerville, MAExecZain Kassam · Somerville, MAExecBenjamin Enerson · Somerville, MAExecAndrew Noh · Somerville, MAExecChris Lange · Somerville, MADirectorJeffery A. Smisek · Somervlle, MADirectorMark Smith · Somerville, MAExec · DirectorAlan A. Gross · Somerville, MADirectorTao R. Wang · Newtown Square, PADirectorAlexander T. Edwards · Boston, MAExecBracken T. Darrell · Boston, MAExec · DirectorCarter G. Mcnabb · Louisville, CODirectorLair G. Kennedy · Louisville, COExecMichael Galgon · Seattle, WADirectorBryan Y. Colwell · New York, NYDirectorAllison Harr · Seattle, WADirectorDavid T. Sinclair · Boston, MAExecKerry Song · San Clemente, CAExecTimothy H. Baynes · Strafford, MODirectorJackie N. Charlesworth · Hong Kong, Hong KongDirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMilton Berlinski · New York, NYDirectorPeter Aberg · New York, NYDirectorTodd Haskins · New York, NYExecMarc N. Puglia · PROVIDENCE, RIExecPatrick Dunn · PROVIDENCE, RIExecHarry W. Lengsfield · NEW YORK, NYExecReiji Morooka · Tokyo, M0Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗